1. Home
  2. CPIX vs BODI Comparison

CPIX vs BODI Comparison

Compare CPIX & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • BODI
  • Stock Information
  • Founded
  • CPIX 1999
  • BODI 1998
  • Country
  • CPIX United States
  • BODI United States
  • Employees
  • CPIX N/A
  • BODI N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • CPIX Health Care
  • BODI Industrials
  • Exchange
  • CPIX Nasdaq
  • BODI Nasdaq
  • Market Cap
  • CPIX 51.5M
  • BODI 46.9M
  • IPO Year
  • CPIX 2009
  • BODI N/A
  • Fundamental
  • Price
  • CPIX $3.30
  • BODI $4.94
  • Analyst Decision
  • CPIX
  • BODI Buy
  • Analyst Count
  • CPIX 0
  • BODI 2
  • Target Price
  • CPIX N/A
  • BODI $10.00
  • AVG Volume (30 Days)
  • CPIX 31.2K
  • BODI 14.8K
  • Earning Date
  • CPIX 11-04-2025
  • BODI 11-07-2025
  • Dividend Yield
  • CPIX N/A
  • BODI N/A
  • EPS Growth
  • CPIX N/A
  • BODI N/A
  • EPS
  • CPIX N/A
  • BODI N/A
  • Revenue
  • CPIX $42,071,813.00
  • BODI $324,871,000.00
  • Revenue This Year
  • CPIX N/A
  • BODI N/A
  • Revenue Next Year
  • CPIX N/A
  • BODI N/A
  • P/E Ratio
  • CPIX N/A
  • BODI N/A
  • Revenue Growth
  • CPIX 11.34
  • BODI N/A
  • 52 Week Low
  • CPIX $1.04
  • BODI $3.38
  • 52 Week High
  • CPIX $7.25
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 47.07
  • BODI 37.05
  • Support Level
  • CPIX $3.41
  • BODI $5.04
  • Resistance Level
  • CPIX $3.54
  • BODI $5.76
  • Average True Range (ATR)
  • CPIX 0.19
  • BODI 0.44
  • MACD
  • CPIX -0.02
  • BODI -0.05
  • Stochastic Oscillator
  • CPIX 23.60
  • BODI 16.96

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: